Article
Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
Gene therapy - 1 Jun 1997
Mineishi S, Nakahara S, Takebe N, Banerjee D, Zhao S C, Bertino J R
Abstract excerpt
We have previously shown that transfer of a mutated dihydrofolate reductase (DHFR) confers resistance to methotrexate (MTX) to infected cells. We report herein the construction of a retrovirus vector, DC/SV6S31tk, which carries the herpes simplex virus thymidine kinase gene (HSVtk) as well as the mutated Serine 31 DHFR (S31) cDNA. 3T3 cells infected with DC/SV6S31tk are more resistant to MTX than cells infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
